Welcome to the new scientist and researcher reference section. Your one-stop shop for the essential resources you need to advance your career.
October 25-27, 2019 | Las Vegas, Nevada
Agenda | SOLD OUT!
Explore the Latest Innovations in Therapy
This two-and-a-half-day conference explores the latest innovations in therapy, including acquiring the knowledge and resources to effectively deliver theranostics agents and the fundamental steps necessary to establish a nuclear medicine therapy program at your institution.
This co-provided workshop, presented by the Society of Nuclear Medicine and Molecular Imaging's (SNMMI) PET Center of Excellence and International Society for Magnetic Resonance in Medicine (ISMRM), will focus on both the technical aspects of PET/MRI as well as the clinical utility of PET/MRI. The workshop will feature a mixture of invited scientific presentations, proffered papers, a poster session, small group discussion, and a keynote lecture. A young investigator award will be presented to students and early stage post-doctoral or physicians that will be selected from the oral paper presentations.
Learn in an intimate setting. Walk away with valuable clinical skills.
The 2020 SNMMI Mid-Winter and ACNM Annual Meeting's intimate format provides an ideal setting to actively collaborate with luminaries in the field, further develop relevant skills, and deliver techniques you can implement immediately when you return to work. This year's meeting will feature three educational tracks open to all attendees, including a dedicated track on Neurology.
The most up-to-date and comprehensive source for nuclear medicine coding and reimbursement information on the web. Please note that ALL information and materials within the SNMMI Coding Corner are direct products of the SNMMI Coding and Reimbursement Working Group.
For Hospitals (APCs, IPPS) Find general coding and reimbursement information for hospitals.
For Private Practices (RBRVS) Find general coding and reimbursement information for professionals in private practices.
Coding and Reimbursement Q&A This easy to use feature contains over 100 questions and answers related to topics such as cardiac, endocrine, neurology, nuclear medicine-related drugs, oncology, PET, PET/CT, radiopharmaceuticals, and more!
In nuclear medicine and molecular imaging, small amounts of radioactive agents are administered to the patient to allow the physician to examine molecular processes within the body. These procedures are highly effective, safe and painless diagnostic tools that present physicians with a detailed view of what’s going on inside an individual’s body at the cellular level. For more than 60 years, these studies have been used to evaluate practically all systems within the body, including the heart and brain, as well as to image many types of cancer.
SNMMI has a large body of knowledge in dose optimization that is continually growing and developing. The dose optimization website presents a wide variety of resources, including SNMMI journal articles, educational offerings, media-related information, links to useful websites and more.
The practice guidelines help to identify those elements of the procedure that are most important in obtaining a high-quality examination, while simultaneously controlling costs. Use of standardized procedures will increase the applicability of clinical research among multiple institutions, in turn, increasing the value of research studies, particularly in the field of technology assessment. In the interest of creating strong, comprehensive documents, some guidelines were formally adopted by SNMMI in collaboration with other professional organizations.
SNMMI's Center for Molecular Imaging Innovation and Translation is an organizational component within the SNMMI that is dedicated to all aspects of molecular imaging in the detection and management of disease. The center is currently facilitating initiatives to bring molecular imaging discoveries from the lab to the patient and to advance "personalized" medicine.
The Clinical Trials Network’s mission is to advance the use of molecular imaging radiopharmaceuticals in clinical trials through standardization of chemistry and imaging methodology. This includes using imaging radiopharmaceuticals during the course of drug development, as well as bringing new agents to regulatory approval. Click here to learn more about the CTN’s Oncology and Neurology Scanner Validation programs, ongoing efforts to harmonize reconstruction parameters in oncology clinical trials, and other services that CTN offers to help scientists advance their research.
SNMMI educational programs are designed to meet the professional development needs of scientists involved in nuclear medicine and molecular imaging endeavors.
On November 1, CMS issued its final rules for HOPPS and MPFS. Thanks to the joint efforts of SNMMI, partner societies, and members, we have great news about nuclear medicine reimbursement for the coming year. Find out more.
(Government Relations News)
In November JNM: A conversation with Uwe Haberkorn … featured articles on Zr-89–anti-STEAP1 PET imaging; F-18-PSMA-1007 uptake with different MA … Hot Topic - I-131 therapy and cancer mortality … State of the Art - VISION and the future of theranostics … and more.
SNMMI participated in Nuclear Science Week, educating congressional staff on the value of nuclear medicine and molecular imaging and receiving the Global Impact Award.
In neuroendocrine tumor treatment, different methods of predicting patient response may be required for different patients. By tailoring the method to the specific patient, physicians may better predict the effectiveness of treatment, according to new research published in The Journal of Nuclear Medicine.
Attention young professionals! Submit your original clinical or scientific abstract for the 2020 ACNM Annual Meeting, January 23-25, 2020 in Tampa Florida.
Submission deadline: November 13, 2019.
SNMMI monitors multiple federal legislative issues and provides resources including issue summaries, letters to Congress, and analysis. Most of this information is in the government relations news section of this web site.
Tools, supported by evidence, to harmonize the practice of nuclear medicine using a progressive and safe approach.